| ATC code A: Alimentary tract and metabolism |
|---|
|
| Other ATC codes |
ATC code A08 Antiobesity preparations, excluding diet products is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup A08 is part of the anatomical group A Alimentary tract and metabolism.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA08.[5] ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
A08A Antiobesity preparations, excluding diet products
A08AA Centrally acting antiobesity products
- A08AA01 Phentermine
- A08AA02 Fenfluramine
- A08AA03 Amfepramone
- A08AA04 Dexfenfluramine
- A08AA05 Mazindol
- A08AA06 Etilamfetamine
- A08AA07 Cathine
- A08AA08 Clobenzorex
- A08AA09 Mefenorex
- A08AA10 Sibutramine
- A08AA11 Lorcaserin
- A08AA12 Setmelanotide
- A08AA51 Phentermine and topiramate
- A08AA56 Ephedrine, combinations
- A08AA62 Bupropion and naltrexone
A08AB Peripherally acting antiobesity products
- A08AB01 Orlistat
- QA08AB90 Mitratapide
- QA08AB91 Dirlotapide
A08AX Other antiobesity drugs
- A08AX01 Rimonabant
See also
- Diet products are in the ATC group V06A.
References
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code A08". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QA08". WHO Collaborating Centre for Drug Statistics Methodology.
This page was last edited on 31 December 2022, at 06:25